Vaccinex, Inc.
Equity & Debt
| Period | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| Dec 2016 | — | $-107.1M | $1.7M |
| Jun 2017 | — | — | $1.2M |
| Sep 2017 | — | $-122.9M | $429.0K |
| Dec 2017 | — | $-125.5M | $4.2M |
| Mar 2018 | — | $-113.3M | $1.3M |
| Jun 2018 | — | $-139.8M | $1.3M |
| Sep 2018 | — | $-218.0K | $11.3M |
| Dec 2018 | — | $-8.6M | $5.6M |
| Mar 2019 | — | $-17.6M | $5.3M |
| Jun 2019 | — | $-26.3M | $5.3M |
| Sep 2019 | — | $-20.0M | $8.6M |
| Dec 2019 | — | $-26.2M | $2.8M |
| Mar 2020 | — | $-25.7M | $2.5M |
| Jun 2020 | $1.1M | $-29.5M | $526.0K |
| Sep 2020 | $1.1M | $-20.2M | $17.1M |
| Dec 2020 | $1.1M | $-26.6M | $10.6M |
| Mar 2021 | $1.1M | $818.0K | $29.4M |
| Jun 2021 | $1.1M | $16.9M | $22.4M |
| Sep 2021 | $1.1M | $11.9M | $13.7M |
| Dec 2021 | $175.0K | $7.4M | $8.6M |
| Mar 2022 | $156.0K | $16.2M | $16.8M |
| Jun 2022 | $138.0K | $10.9M | $11.4M |
| Sep 2022 | $119.0K | $6.3M | $7.2M |
| Dec 2022 | $101.0K | $5.2M | $6.4M |
| Mar 2023 | $82.0K | $2.4M | $3.3M |
| Jun 2023 | $63.0K | $-423.0K | $1.9M |
| Sep 2023 | $44.0K | $-3.9M | $127.0K |
| Dec 2023 | $26.0K | $-2.3M | $1.5M |
| Mar 2024 | $6.0K | $2.7M | $3.0M |
| Jun 2024 | — | $-2.9M | $233.0K |
| Sep 2024 | — | $-1.3M | $2.9M |
| Dec 2024 | $0 | $-2.5M | $1.1M |